Elliquence
Private Company
Funding information not available
Overview
Elliquence is a long-established, private medical device company focused on innovative, minimally invasive solutions for spine and neurosurgical procedures. Its technology platform centers on advanced radiowave (radiofrequency) ablation and endoscopic visualization systems, which are marketed under the 'Less is More' philosophy to enable tissue-preserving surgeries. The company has a commercial portfolio of products, generates revenue through device sales, and supports its market presence with extensive surgical training and workshops for healthcare professionals. Elliquence operates globally, serving the US, EMEA, and South American markets from its headquarters in Baldwin, New York.
Technology Platform
Integrated platform combining advanced radiofrequency (Radiowave) energy for ablation, coagulation, and tissue modulation with high-definition endoscopic visualization systems for minimally invasive spine and neurosurgical procedures.
Opportunities
Risk Factors
Competitive Landscape
Elliquence competes in the specialized segment of endoscopic and RF-based spine devices. Major competitors include global ortho-spine giants like Medtronic, Stryker, and Johnson & Johnson, as well as other focused players such as Joimax GmbH (endoscopic spine) and various surgical energy device companies. Its differentiation lies in its integrated RF-endoscopy platform and deep focus on surgeon training.